Stuart L. Goldstein, MD, FAAP, FNKF
- Clark D. West Endowed Chair
- Director, Center for Acute Care Nephrology
- Medical Director, Pheresis Service
- Co-Director, Heart Institute Research Core
- Professor, UC Department of Pediatrics
- stuart.goldstein@cchmc.org
- Board Certified
About
Biography
As a pediatric kidney specialist, I treat children and adolescents in all areas of pediatric nephrology. These include general nephrology, acute kidney injury (AKI), dialysis, transplantation and tuberous sclerosis. I also consult on fetal care if there is a problem with the unborn baby’s kidneys.
I was drawn to the field of nephrology by the opportunity it presents to improve the outcomes for children with kidney problems. Working with children and their families, I help patients reach their full potential. Nephrology also allows me to practice across the entire spectrum of pediatric illness, from acute critical care, to chronic care and outpatient care.
My research is focused on short- and long-term outcomes for children who have AKI and those who are at risk for AKI. I’m interested in AKI epidemiology and outcomes, acute renal replacement therapy and investigation of novel urinary AKI biomarkers in the pediatric population.
In 2012, I established Prospective Pediatric AKI Research Group (ppAKI-RG). The ppAKI-RG is comprised of more than 60 centers around the world with the goal of improving outcomes for the child with, or at-risk for, AKI. This consortium focuses on multicentered research studies that are dedicated to understanding and treating AKI in pediatric patients. This group has completed three major, unprecedented national and international studies to accurately characterize pediatric AKI epidemiology, reduce AKI and improve patient outcomes.
I also developed the only pediatric-specific, acute-care nephrology subspecialty fellowship with graduates who are now leaders in the field of pediatric AKI.
MD: Columbia College of Physicians and Surgeons, New York, NY, 1990.
Residency: Baylor College of Medicine, Houston, TX.
Fellowship: Pediatric Nephrology, Children's Hospital, Boston, MA.
Interests
Acute kidney injury; continuous renal replacement therapy; cardio-renal syndrome; nephrotoxic medication associated morbidity
Services and Specialties
Nephrology and Hypertension, Dialysis, End-Stage Renal Disease, Tuberous Sclerosis, Nephrology - Acute Care, Heart, Colorectal Disorders, Fontan Management
Interests
Acute kidney injury epidemiology and biomarkers; heart failure associated chronic kidney disease; nephrotoxic medication associated acute kidney injury reduction
Research Areas
Cardiology, Nephrology and Hypertension, Heart
Additional Languages
Spanish
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock. Pediatric Nephrology. 2023.
Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure. Pediatric Nephrology. 2023; 38:927-931.
Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children. 2023; 4:326-332.
Hypernatremia Correction in Children: Maybe Slow but Steady Does Not Win the Race?. Clinical journal of the American Society of Nephrology : CJASN. 2023; 18:292-293.
WCN23-0514 Long-term kidney outcomes following pediatric acute kidney injury not receiving dialysis: A population-based propensity-matched cohort study. Kidney International Reports. 2023; 8:s8-s9.
Impact of the Magnitude and Timing of Fluid Overload on Outcomes in Critically Ill Children: A Report From the Multicenter International Assessment of Worldwide Acute Kidney Injury, Renal Angina, and Epidemiology (AWARE) Study. Critical Care Medicine. 2023.
Premature infants born <28 weeks with acute kidney injury have increased bronchopulmonary dysplasia rates. Pediatric Research. 2023.
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury. Journal of Antimicrobial Chemotherapy. 2023; 78:478-487.
Nephrotoxin Exposure and Acute Kidney Injury in Adults. Clinical journal of the American Society of Nephrology : CJASN. 2023; 18:163-172.
First-Time Use of the Seraph® 100 Microbind® Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A Case Report. Case Reports in Nephrology and Dialysis. 2023; 13:1-6.
From the Blog
For Continuous Dialysis Nafamostat Shows Similar Efficacy, Lower Toxicity, Lower Costs vs. Citrate
Stuart L. Goldstein, MD, FAAP, FNKF4/5/2022
Better AWAREness of Acute Kidney Injury Could Transform Intensive Care
Stuart L. Goldstein, MD, FAAP, FNKF6/30/2019
7 Things Parents Need To Know About Nephrotoxic Medications
3/10/2016
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2022 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey